PB 99 of 2011
National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2011 (No. 12)
National Health Act 1953
___________________________________________________________________________
I, FELICITY McNEILL, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Amendment Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.
Dated 9 December 2011
FELICITY McNEILL
First Assistant Secretary (Acting)
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________________
1 Name of Instrument
(1) This Instrument is the National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2011 (No.12).
(2) This Instrument may also be cited as PB 99 of 2011.
2 Commencement
This Instrument commences on 1 January 2012.
3 Amendments to PB 116 of 2010
Schedule 1 amends the National Health (Highly specialised drugs program for hospitals) Special Arrangement 2010 (PB 116 of 2010).
Schedule 1 Amendments
[1] Section 4, definition of CAR drug, paragraph (m)
omit:
Romiplostin
substitute:
Romiplostim
[2] Section 24, paragraph (2)(k)
omit:
Romiplostin
substitute:
Romiplostim
[3] Section 24, paragraph (2)(l)
omit (all instances):
Romiplostin
substitute:
Romiplostim
[4] Section 24, paragraph (2)(m)
omit (all instances):
Romiplostin
substitute:
Romiplostim
[5] Section 24, paragraph (2)(n)
omit (all instances):
Romiplostin
substitute:
Romiplostim
[6] Section 25, paragraph (2)(p)
omit:
Romiplostin
substitute:
Romiplostim
[7] Section 25, paragraph (2)(q)
omit (all instances):
Romiplostin
substitute:
Romiplostim
[8] Section 25, paragraph (2)(r)
omit (all instances):
Romiplostin
substitute:
Romiplostim
[9] Section 25, paragraph (2)(s)
omit (all instances):
Romiplostin
substitute:
Romiplostim
[10] Schedule 1, after entry for Epoprostenol in the form Powder for I.V. infusion 500 mcg (as sodium) with diluent
insert:
Powder for IV infusion 500 micrograms (as sodium) infusion administration set
Injection
Flolan Kit
GK
EMP
C3163 C3164 C3165 C3166 C3167
See Note 1
See Note 2
D
[11] Schedule 1, after entry for Epoprostenol in the form Powder for I.V. infusion 1.5 mg (as sodium) with diluent
insert:
Powder for IV infusion 1.5 mg (as sodium) infusion administration set
Injection
Flolan Kit
GK
EMP
C3163 C3164 C3165 C3166 C3167
See Note 1
See Note 2
D
[12] Schedule 1, after entry for Etravirine in the form Tablet 100 mg
insert:
Tablet 200 mg
Oral
Intelence
JC
EMP
C3596 C3597
120
5
D
[13] Schedule 1, omit entry for Peginterferon Alfa-2b
[14] Schedule 1, entry for Romiplostin
omit from the column headed ‘Listed Drug’:
Romiplostin
substitute:
Romiplostim
[15] Schedule 1, entry for Tacrolimus in the form Capsule 500 micrograms:
omit from the column headed ‘form’:
Capsule 500 micrograms
substitute:
Capsule 0.5 mg
[16] Schedule 3, omit entry for Peginterferon Alfa-2b
[17] Schedule 3, entry for Romiplostin
omit from the column headed ‘Listed Drug’:
Romiplostin
substitute:
Romiplostim
[18] Schedule 3, entry for Romiplostin, circumstances code C3852
omit from the column headed ‘Circumstances and Purposes’ (all instances):
Romiplostin
substitute:
Romiplostim
[19] Schedule 3, entry for Romiplostin, circumstances code C3853
omit from the column headed ‘Circumstances and Purposes’ (all instances):
Romiplostin
substitute:
Romiplostim
[20] Schedule 3, entry for Romiplostin, circumstances code C3854
omit from the column headed ‘Circumstances and Purposes’ (all instances):
Romiplostin
substitute:
Romiplostim
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.
